Human telomerase reverse transcriptase polypeptides

Details Human telomerase reverse transcriptase polypeptides Human telomerase reverse transcriptase polypeptides

2004-06-24

2009-11-24

Canella, Karen A (Department: 1642)

Chemistry: natural resins or derivatives; peptides or proteins;

Peptides of 3 to 100 amino acid residues

C530S328000, C514S002600, C514S015800, C514S016700

Reexamination Certificate

active

07622549

ABSTRACT:
The invention provides compositions and methods related to human telomerase reverse transcriptase (hTRT), the catalytic protein subunit of human telomerase. The polynucleotides and polypeptides of the invention are useful for diagnosis, prognosis and treatment of human diseases, for changing the proliferative capacity of cells and organisms, and for identification and screening of compounds and treatments useful for treatment of diseases such as cancers.

REFERENCES:
patent: 3817837 (1974-06-01), Tanenholtz et al.
patent: 3850752 (1974-11-01), Schuurs et al.
patent: 3939350 (1976-02-01), Kronick et al.
patent: 3996345 (1976-12-01), Ullman et al.
patent: 4275149 (1981-06-01), Litman et al.
patent: 4277437 (1981-07-01), Maggio
patent: 4366241 (1982-12-01), Tom et al.
patent: 4554101 (1985-11-01), Hopp
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4683202 (1987-07-01), Mullis
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 4889806 (1989-12-01), Olson et al.
patent: 4965188 (1990-10-01), Mullis et al.
patent: 5001225 (1991-03-01), Taylor
patent: 5075227 (1991-12-01), Hagen
patent: 5489508 (1996-02-01), West et al.
patent: 5583016 (1996-12-01), Villeponteau et al.
patent: 5597697 (1997-01-01), Diamond
patent: 5639613 (1997-06-01), Shay et al.
patent: 5747317 (1998-05-01), Cao
patent: 5770422 (1998-06-01), Collins
patent: 5853719 (1998-12-01), Nair et al.
patent: 5917025 (1999-06-01), Collins
patent: 5919656 (1999-07-01), Harrington et al.
patent: 5919676 (1999-07-01), Graham et al.
patent: 6093809 (2000-07-01), Cech et al.
patent: 6120764 (2000-09-01), Graham et al.
patent: 6140087 (2000-10-01), Graham et al.
patent: 6166178 (2000-12-01), Cech et al.
patent: 6258535 (2001-07-01), Villeponteau et al.
patent: 6261556 (2001-07-01), Weinrich et al.
patent: 6261836 (2001-07-01), Cech et al.
patent: 6306388 (2001-10-01), Nair et al.
patent: 6309867 (2001-10-01), Cech et al.
patent: 6337200 (2002-01-01), Morin
patent: 6387701 (2002-05-01), Nair et al.
patent: 6440735 (2002-08-01), Gaeta
patent: 6444650 (2002-09-01), Cech et al.
patent: 6475789 (2002-11-01), Cech et al.
patent: 6517834 (2003-02-01), Weinrich et al.
patent: 6545133 (2003-04-01), Weinrich et al.
patent: 6608188 (2003-08-01), Tsuchiya et al.
patent: 6610839 (2003-08-01), Morin et al.
patent: 6617110 (2003-09-01), Cech et al.
patent: 6627619 (2003-09-01), Cech et al.
patent: 6767719 (2004-07-01), Morin et al.
patent: 6777203 (2004-08-01), Morin et al.
patent: 6787133 (2004-09-01), Weinrich et al.
patent: 6808880 (2004-10-01), Cech et al.
patent: 6846662 (2005-01-01), Kilian et al.
patent: 6916642 (2005-07-01), Kilian et al.
patent: 6921664 (2005-07-01), Cech et al.
patent: 6927285 (2005-08-01), Cech et al.
patent: 7005262 (2006-02-01), Cech et al.
patent: 7056513 (2006-06-01), Cech et al.
patent: 7091021 (2006-08-01), Morin
patent: 7195911 (2007-03-01), Cech et al.
patent: 7262174 (2007-08-01), Jiang et al.
patent: 7262288 (2007-08-01), Cech et al.
patent: 7285639 (2007-10-01), Cech et al.
patent: 7297488 (2007-11-01), Cech et al.
patent: 7378244 (2008-05-01), Morin et al.
patent: 2002/0164786 (2002-11-01), Cech et al.
patent: 2002/0187471 (2002-12-01), Cech et al.
patent: 2003/0009019 (2003-01-01), Cech et al.
patent: 2003/0032075 (2003-02-01), Cech et al.
patent: 2003/0044394 (2003-03-01), Gaeta et al.
patent: 2003/0059787 (2003-03-01), Cech et al.
patent: 2003/0096344 (2003-05-01), Cech et al.
patent: 2003/0100093 (2003-05-01), Cech et al.
patent: 2004/0072787 (2004-04-01), Morin et al.
patent: 2004/0242529 (2004-12-01), Cech et al.
patent: 2004/0247613 (2004-12-01), Cech et al.
patent: 2004/0253701 (2004-12-01), Morin et al.
patent: 2005/0013825 (2005-01-01), Cech et al.
patent: 2006/0040307 (2006-02-01), Cech et al.
patent: 2006/0204483 (2006-09-01), Gaeta et al.
patent: 2 194 393 (1996-01-01), None
patent: 2271718 (1998-05-01), None
patent: 0 799 315 (1997-10-01), None
patent: 1 093 381 (2003-08-01), None
patent: 2 317 891 (1998-04-01), None
patent: 9154575 (1997-06-01), None
patent: WO 82/01461 (1982-05-01), None
patent: WO 84/03564 (1984-09-01), None
patent: WO 93/23572 (1993-11-01), None
patent: WO 94/17210 (1994-08-01), None
patent: WO 95/13382 (1995-05-01), None
patent: WO 96/01835 (1996-01-01), None
patent: WO 96/12811 (1996-05-01), None
patent: WO 96/19580 (1996-06-01), None
patent: WO 96/40868 (1996-12-01), None
patent: WO 97/38013 (1997-10-01), None
patent: WO 98/01542 (1998-01-01), None
patent: WO 98/01543 (1998-01-01), None
patent: WO 98/07838 (1998-02-01), None
patent: WO 98/08938 (1998-03-01), None
patent: WO 98/14592 (1998-04-01), None
patent: WO 98/14593 (1998-04-01), None
patent: WO 98/21343 (1998-05-01), None
patent: WO 98/23759 (1998-06-01), None
patent: WO 98/37181 (1998-08-01), None
patent: WO 98/45450 (1998-10-01), None
patent: WO 98/59040 (1998-12-01), None
patent: WO 99/01560 (1999-01-01), None
patent: WO 99/33998 (1999-07-01), None
patent: WO 99/38964 (1999-08-01), None
patent: WO 99/63945 (1999-12-01), None
patent: WO 00/02581 (2000-01-01), None
patent: WO 00/46355 (2000-08-01), None
patent: WO 00/61766 (2000-10-01), None
patent: WO 00/73420 (2000-12-01), None
patent: WO 01/60391 (2001-08-01), None
patent: WO 02/094213 (2002-11-01), None
patent: WO 03/038047 (2003-05-01), None
Roitt et al (Immunology, 1993, Mosby, St. Louis, p. 7.7-7.8).
Herbert et al (The Dictionary of Immunology, Academic Press, 3rd Edition, London, 1985, pp. 58-59).
Holmes (Exp. Opin.Invest. Drugs, 2001, 10(3):511-519).
Bowie et al (Science, 1990, 257:1306-1310).
Janeway et al. (Immunobiology, 1997, p. G:1).
Sambrook et al (Molecular Cloning, A Laboratory Manual, Cold Spring Harbor, 1989, p. 16.3-36).
U.S. Appl. No. 09/721,477, Cech et al.
U.S. Appl. No. 09/721,506, Cech et al.
U.S. Appl. No. 09/974,584, Cech et al.
Malicki, J. et al. “A humanHOX4Bregulatory element provides head-specific expression inDrosophilaembryos”, Nature, Jul. 23, 1992, pp. 345-357, vol. 358.
McEachern, M. & Blackburn, E. “Runaway telomere elongation caused by telomerase RNA gene mutations,”Nature, Aug. 1995, pp. 403-409, vol. 376.
Melby, P. et al. “Quantitative measurement of human cytokine gene expression by polymerase chain reaction,”J. Immunol. Meth., 1993, pp. 235-244, vol. 159.
Merrifield, R.B. “Solid phase peptide synthesis. I. The synthesis of a tetrapeptide,”J. Am. Chem. Soc., Jul. 1963, pp. 2149-2154, vol. 85.
Meyerson, M. et al., “hEST2, the Putative Human Telomerase Catalytic Subunit Gene, Is Up-Regulated in Tumor Cells and during Immortalization,”Cell, Aug. 1997, pp. 785-795, vol. 90.
Microbix Biosystems, Inc.; Admax™ adenovirus creation kits. www.
Murasawa et al. “Constitutive human telomerase reverse transcriptase expression enhances regenerative properties of endothelial progenitor cells”,Circulation, 2002, pp. 1133-1139, vol. 106.
Murray,In McGraw Hill Yearbook of Science and Technology, 1992, pp. 191-196, McGraw Hill, New York.
Nakamura, T. et al., “Telomerase Catalytic Subunit Homologs from Fission Yeast and Human,”Science, Aug. 1997, pp. 955-959, vol. 277.
Nakayama et al. “TLP1: A Gene Encoding a Protein Component of Mammalian Telomerase Is a Novel Member of WD Repeats Family,”Cell, 1997, pp. 875-884, vol. 88.
Nakayama, J. et al. “Cloning of a Candidate cDNA Encoding a Proteinaceous Component of Mammalian Telomerase”,Molecular Biology Cell Abstracts Supp. 7, 1996, p. 875-884, 286a Section 1664.
Natarajan et al. “Major histocompatibility complex determinants select T-cell receptor alpha chain variable region dominance in a peptide-specific response.”Proc. Natl. Acad. Sci., Oct. 1992, pp. 8874-8878, vol. 19.
Nielsen et al., “Peptide nucleic acids (PNAs): Potential antisense and anti-gene agents,”Anticancer Drug Des., 1993, pp. 53-63, vol. 8.
O'Hare et al.,Proc. Natl. Acad. Sciences; Jan. 16, 2001; pp. 646-651, vol. 98.
U.S. Appl. No. 10/877,146, Cech et al.
U.S. Appl. No. 10/877,022, Cech et al.
Claims for U.S. Patent No. 6,093,809.
Claims for U.S. Patent No. 6,

Affiliated with

Also associated with

Rating

Human telomerase reverse transcriptase polypeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Human telomerase reverse transcriptase polypeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human telomerase reverse transcriptase polypeptides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4140237